Cloning and characterization of the promoter region of human focal adhesion kinase gene: Nuclear factor kappa B and p53 binding sites

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1678, Issue 2-3, 2004, Pages 111-125

  Golubovskaya, Vita ^a   Kaur, Aparna ^a   Cance, William ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Focal adhesion kinase (FAK); Gene expression; Gene regulation; Promoter; Transcription

Indexed keywords

FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME ACTIVITY; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPORTER GENE; REPRESSOR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE; CELL NUCLEUS; CLONING, MOLECULAR; DNA PRIMERS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2442583529     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2004.03.002     Document Type: Article

References (48)

1. Hanks S.K., Polte T.R. Signaling through focal adhesion kinase. BioEssays. 19:1997;137-145
2. Zachary I. Focal adhesion kinase. Int. J. Biochem. Cell Biol. 29:1997;929-934
3. Hauck C.R., Sieg D.J., Hsia D.A., Loftus J.C., Gaarde W.A., Monia B.P., Schlaepfer D.D. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 61:2001;7079-7090
4. Xu L.H., Yang X.-H., Bradham C.A., Brenner D.A., Baldwin A.S., Craven R.J., Cance W.G. The focal adhesion kinase suppresses transformation-associated, anchorage-Independent apoptosis in human breast cancer cells. J. Biol. Chem. 275:2000;30597-30604
5. Golubovskaya V., Beviglia L., Xu L.H., Earp H.S., Craven R., Cance W. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J. Biol. Chem. 277:2002;38978-38987
6. Schaller M.D., Borgman C.A., Cobb B.S., Vines R.R., Reynolds A.B., Parsons J.T. pp125fak a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5192-5196
7. Hanks S.K., Calalb M.B., Harper M.C., Patel S.K. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8487-8491
8. Whitney G.S., Chan P.Y., Blake J., Cosand W.L., Neubauer M.G., Aruffo A., Kanner S.B. Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. DNA Cell Biol. 12:1993;823-830
9. Weiner T.M., Liu E.T., Craven R.J., Cance W.G. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 342:1993;1024-1025
10. Fiedorek F.T., Kay E.S. Mapping of the focal adhesion kinase (Fadk) gene to mouse chromosome 15 and human chromosome 8. Mamm. Genome. 6:1995;123-126
11. Agochiya M., Brunton V.G., Owens D.W., Parkinson E.K., Paraskeva C., Keith W.N., Frame M.C. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene. 18:1999;5646-5653
12. Weiner T.M., Liu E.T., Craven R.J., Cance W.G. Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann. Surg. Oncol. 1:1994;18-27
13. Owens L.V., Xu L., Craven R.J., Dent G.A., Weiner T.M., Kornberg L., Liu E.T., Cance W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755
14. Owens L.V., Xu L., Dent G.A., Yang X., Sturge G.C., Craven R.J., Cance W.G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3:1996;100-105
15. Cance W.G., Harris J.E., Iacocca M.V., Roche E., Yang X., Chang J., Simkins S., Xu L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6:2000;2417-2423
16. Xu L.H., Yang X., Craven R.J., Cance W.G. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ. 9:1998;999-1005
17. Lark A.L., Livasy C.A., Calvo B., Caskey L., Moore D.T., Yang X., Cance W.G. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9:2003;215-222
18. Filatov L., Golubovskaya V., Hurt J.C., Byrd L.L., Phillips J.M., Kaufmann W.K. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene. 16:1998;1825-1838
19. Finco T.S., Beg A.A., Baldwin A.S. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. U. S. A. 91:1994;11884-11888
20. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 16:1997;6018-6033
21. Kume A., Nishiura H., Suda J., Suda T. Focal adhesion kinase upregulated by granulocyte-macrophage colony-stimulating factor but not by interleukin-3 in differentiating myeloid cells. Blood. 89:1997;3434-3442
22. Judson P.L., He X., Cance W.G., Van Le L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer. 86:1999;1551-1556
23. Han N.M., Fleming R.Y., Curley S.A., Gallick G.E. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann. Surg. Oncol. 4:1997;264-268
24. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 404:2000;892-897
25. Sellers W.R., Fisher D.E. Apoptosis and cancer drug targeting. J. Clin. Invest. 104:1999;1655-1661
26. van De Water B., Houtepen F., Huigsloot M., Tijdens I.B. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. J. Biol. Chem. 276:2001;36183-36193
27. Zhao J., Pestell R., Guan J.L. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol. Biol. Cell. 12:2001;4066-4077
28. Ilic D., Almeida E.A., Schlaepfer D.D., Dazin P., Aizawa S., Damsky C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143:1998;547-560
29. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331
30. Hoffman W.H., Biade S., Zilfou J.T., Chen J., Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277:2002;3247-3257
31. Wu Y., Mehew J.W., Heckman C.A., Arcinas M., Boxer L.M. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene. 20:2001;240-251
32. Murphy M., Hinman A., Levine A.J. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10:1996;2971-2980
33. Johnsen J.I., Aurelio O.N., Kwaja Z., Jorgensen G.E., Pellegata N.S., Plattner R., Stanbridge E.J., Cajot J.F. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int. J. Cancer. 88:2000;685-691
34. Krause K., Wasner M., Reinhard W., Haugwitz U., Dohna C.L., Mossner J., Engeland K. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res. 28:2000;4410-4418
35. Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene. 20:2001;1803-1815
36. Krause K., Haugwitz U., Wasner M., Wiedmann M., Mossner J., Engeland K. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem. Biophys. Res. Commun. 284:2001;743-750
37. Guerrero S., Figueras A., Casanova I., Farre L., Lloveras B., Capella G., Trias M., Mangues R. Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice. FASEB J. 16:2002;1642-1644
38. Meneveri R., Agresti A., Marozzi A., Saccone S., Rocchi M., Archidiacono N., Corneo G., Della Valle G., Ginelli E. Molecular organization and chromosomal location of human GC-rich heterochromatic blocks. Gene. 123:1993;227-234
39. Fisher R.C., Scott E.W. Role of PU.1 in hematopoiesis. Stem Cells. 16:1998;25-37
40. Hayashi S., Yamane T., Miyamoto A., Hemmi H., Tagaya H., Tanio Y., Kanda H., Yamazaki H., Kunisada T. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem. Cell. Biol. 76:1998;911-922
41. Huang R.P., Darland T., Okamura D., Mercola D., Adamson E.D. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene. 9:1994;1367-1377
42. Huang R.P., Fan Y., de Belle I., Niemeyer C., Gottardis M.M., Mercola D., Adamson E.D. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int. J. Cancer. 72:1997;102-109
43. Liu J., Grogan L., Nau M.M., Allegra C.J., Chu E., Wright J.J. Physical interaction between p53 and primary response gene Egr-1. Int. J. Oncol. 18:2001;863-870
44. Nair P., Muthukkumar S., Sells S.F., Han S.S., Sukhatme V.P., Rangnekar V.M. Early growth response-1-dependent apoptosis is mediated by p53. J. Biol. Chem. 272:1997;20131-20138
45. Wu M.Y., Liang Y.R., Wu X.Y., Zhuang C.X. Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions. World J. Gastroenterol. 8:2002;971-975
46. Virolle T., Adamson E.D., Baron V., Birle D., Mercola D., Mustelin T., de Belle I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3:2001;1124-1128
47. Tamura M., Gu J., Danen E.H., Takino T., Miyamoto S., Yamada K.M. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 274:1999;20693-20703
48. Yen L., Benlimame N., Nie Z.R., Xiao D., Wang T., Moustafa A.E., Esumi H., Milanini J., Hynes N.E., Pages G., Alaoui-Jamali M.A. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Mol. Biol. Cell. 13:2002;4029-4044